In a study looking at the dynamics of ASCT2 across different prostate cancer states, ASCT2 expression appeared to have an overall minor decrease from androgen-sensitive to castration-resistant states, which is consistent with our data [27]. The gene discussed is SLC1A5; the disease is prostate cancer.